TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

Neoadjuvant Nivolumab with or without Ipilimumab for Cisplatin-Ineligible Patients with Muscle-Invasive Bladder Cancer.

Brendan J Guercio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.